发明授权
EP1769795B1 Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
有权
Arylharnstoffverbindungen在与其他细胞生长抑制剂或细胞毒性药物联合用于人类治疗癌症
- 专利标题： Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
- 专利标题（中）： Arylharnstoffverbindungen在与其他细胞生长抑制剂或细胞毒性药物联合用于人类治疗癌症
-
申请号： EP06023696.5申请日： 2002-12-03
-
公开(公告)号： EP1769795B1公开(公告)日： 2013-07-24
- 发明人: Carter, Christopher A. , Gibson, Neil , Hibner, Barbara , Humphrey, Rachel W. , Trail, Pamela , Vincent, Patrick W. , Zhai, Yifan
- 申请人： Bayer HealthCare LLC
- 申请人地址： 555 White Plains Road Tarrytown, NY 10591 US
- 专利权人： Bayer HealthCare LLC
- 当前专利权人： Bayer HealthCare LLC
- 当前专利权人地址： 555 White Plains Road Tarrytown, NY 10591 US
- 代理机构： Weiss, Wolfgang
- 优先权： US334609P 20011203
- 主分类号： A61K31/44
- IPC分类号： A61K31/44 ; A61K31/535 ; A61K31/65 ; A61K31/435 ; A61K31/505 ; A61K31/47
摘要：
This invention relates to aryl urea compounds in combination with cytotoxic or cytostatic agents for use in treating raf kinase mediated diseases such as cancer
公开/授权文献
信息查询
